RIL
PCVX icon

Rothschild Investment LLC’s Vaxcyte PCVX Stock Holding History

Rothschild Investment LLC’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.8K Buy
238
+49
+26% +$2.66K ﹤0.01% 1711
2026
Q1 		$11K Buy
189
+28
+17% +$1.52K ﹤0.01% 1649
2025
Q4 		$7.43K Buy
161
+26
+19% +$1.16K ﹤0.01% 1699
2025
Q3 		$4.86K Sell
135
-90
-40% -$2.98K ﹤0.01% 1719
2025
Q2 		$7.32K Buy
225
+140
+165% +$4.59K ﹤0.01% 1339
2025
Q1 		$3.21K Sell
85
-10
-11% -$800 ﹤0.01% 1647
2024
Q4 		$7.78K Sell
95
-10
-10% -$993 ﹤0.01% 1208
2024
Q3 		$12K Buy
105
+65
+163% +$5.86K ﹤0.01% 1119
2024
Q2 		$3.02K Buy
40
+30
+300% +$2.04K ﹤0.01% 1283
2024
Q1 		$683 Buy
+10
New +$692 ﹤0.01% 1299

Other funds holding PCVX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Rothschild Investment LLC's PCVX Position: Q2 2026 in Review

Rothschild Investment LLC increased its Vaxcyte (PCVX) stake by 26% in Q2 2026, buying an estimated $2.66K and bringing the position to 238 shares worth $13.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1711.

Rothschild Investment LLC first reported a position in PCVX in Q1 2024 and has held it in 10 quarters since. 331 funds tracked by Wall St. Rank hold PCVX as of Q2 2026.

  • Rothschild Investment LLC held 238 shares of Vaxcyte worth $13.8K as of Q2 2026.
  • Rothschild Investment LLC bought 49 Vaxcyte shares in Q2 2026, an estimated $2.66K.
  • Vaxcyte made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #1711 holding.
  • Rothschild Investment LLC first reported a position in Vaxcyte in Q1 2024 and has held it in 10 quarters since.
  • 331 funds tracked by Wall St. Rank held Vaxcyte as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.